Aries Pharmaceuticals, Inc. (Aries) is a specialty pharmaceutical company commercializing best-in-class gastroenterology products for the United States market with a focus on products used in endoscopy and for the treatment of select gastrointestinal diseases. Aries is a wholly owned subsidiary of Cosmo Pharmaceuticals N.V. (Cosmo) whose vision to enter the U.S. market was realized with creation of Aries in 2017.
The Aries portfolio of products is licensed from Cosmo, a specialty pharmaceutical company, headquartered in Dublin. Cosmo’s products and clinical development pipeline seek to address unmet needs in the diagnosis and treatment of colon diseases, specifically focusing on innovative treatments for Inflammatory Bowel Diseases (IBD), colorectal cancer and colon infections. Cosmo’s proprietary MMX® technology is at the core of several of Aries’ pipeline products.
For more information on Cosmo Pharmaceuticals, visit www.CosmoPharma.com